976 / 1851
Vansteenkiste J, et al. Ann Oncol. 2013;24
The preferred treatment of
unresectable LA-NSCLC is definitive
concurrent chemotherapy and radiotherapy
[I, A].
Definitive
thoracic radiotherapy should be no less than
the biological
equivalent of
60 Gy in 2.0 Gy fractions
[I, A].
In patients who are
unfit to receive concurrent
chemotherapy and
radiotherapy, the
sequential approach
should be offered as an
alternative
treatment with curative intent
[I, A].